Three year trends in the use of emerging tobacco products
Methods: In 2010-2012, we applied a mixed-mode survey to obtain annual, representative samples of US adults.
Results: In weighted analysis, lifetime prevalence of snus use (5.1% to 6.5%) and water pipe (8.8% to 9.9%) did not significantly change from 2011-12. Lifetime prevalence of electronic cigarettes increased from 1.8% to 10.8%, p <.001. In 2012, daily smokers (44.8%) and nondaily smokers (24.5%) were the most likely to have tried electronic cigarettes, compared to former smokers (7.5%) and never smokers (1.7%). Younger (12.8%) and middle aged adults (13.4%) compared to older adults (2.4%) and those without a high school degree (10.9% vs 7.4%) were more likely to have tried electronic cigarettes (p<.05 for all comparisons). In multivariable analysis, current daily (OR=53.3 , 95% CI = 34.083.6), nondaily (20.2, 11.037.2), and former smoking status (6.6, 4.110.5) remained significant, as did young (7.2, 3.515.0) and middle aged adults (6.7, 3.9-11.3).
Conclusion: Use of emerging tobacco products raises concerns about nonsmokers being at risk for nicotine dependence, current smokers maintaining their dependence, and the impact of poly-tobacco use. Greater awareness of emerging tobacco product prevalence and the high risk demographic user groups will inform efforts to determine appropriate public health policy and regulatory action.
Learning Areas:Public health or related research
Social and behavioral sciences
Describe the three year trend in use of emerging tobacco products.
Keyword(s): Tobacco Policy, Tobacco Control
Qualified on the content I am responsible for because: I direct the National Social Climate Survey of Tobacco Control through a cooperative project with the Social Science Research Center and the American Academy of Pediatricsâ Julius B. Richmond Center. I also serves as Principal Investigator for the Surveillance and Evaluation Services grant for the Mississippi State Department of Healthâs Office of Tobacco Control.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.